$MRNA “Charles Elson, a corporate governance expert at the University of Delaware, said the Moderna stock sales underscore why he has always believed executives should not sell stock while they are at the company. "Even if it can be done legally, the optics are terrible because it shows you have a better place to put your money," said Elson. "It shows a lack of confidence in your company going forward."